Inhibrx Inc (INBX) is around the top of the Biotechnology industry according to InvestorsObserver. INBX received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Inhibrx Inc also achieved a score of 80 in the Biotechnology industry, putting it above 80 percent of Biotechnology stocks. Biotechnology is ranked 25 out of the 148 industries.
INBX has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on INBX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Inhibrx Inc Stock Today?
Inhibrx Inc (INBX) stock has fallen -0.78% while the S&P 500 is higher by 1.4% as of 12:30 PM on Friday, May 5. INBX has fallen -$0.21 from the previous closing price of $26.91 on volume of 107,862 shares. Over the past year the S&P 500 has fallen -0.70% while INBX is higher by 58.08%. INBX lost -$3.62 per share the over the last 12 months.
Click Here to get the full Stock Report for Inhibrx Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
